Weekly Digest – 18-24 Jul 2023 Weekly Digest – 18-24 Jul 2023 21 Jul 2023: Opdivo (Nivolumab) / Completely Resected Stage IIB or IIC Melanoma / BMS: Received positive EU CHMP opinion The recommendation was based on results from the […]
Weekly Digest – 18-24 Jul 2023 Weekly Digest – 18-24 Jul 2023 21 Jul 2023: Pembrolizumab / Trastuzumab / HER2+ Advance Gastric or GEJ Adenocarcinoma Expressing PD-L1 (CPS ≥1) / Merck: Received positive EU CHMP opinion The recommendation was based […]
Weekly Digest – 18-24 Jul 2023 Weekly Digest – 18-24 Jul 2023 19 Jul 2023: Toripalimab / 1L ES-SCLC / Junshi Biosciences: The China NMPA accepted the sNDA for review Junshi Biosciences seeks NMPA approval for Toripalimab in combination with […]
Weekly Digest – 18-24 Jul 2023 Weekly Digest – 18-24 Jul 2023 19 Jul 2023: KEYTRUDA (Pembrolizumab) / Newly diagnosed cervical cancer/ Merck: Phase 3 KEYNOTE-A18 trial met the primary endpoints of PFS Phase 3 KEYNOTE-A18 trial evaluating Pembro + […]
